Dyne Therapeutics, Inc.(DYN)内部人交易:高管与董事近期交易
过去 18 个月,共有 8 位内部人为 Dyne Therapeutics, Inc.(DYN)报告了 153 笔 Form 4 交易(最近一笔 2026-11-16)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-16 | Cox John | CEO & President | 卖出 | 5,513 | $92,729 |
| 2026-11-16 | Lucera Erick | Chief Financial Officer | 卖出 | 1,991 | $33,489 |
| 2026-11-16 | Kerr Douglas | Head of R&D and CMO | 卖出 | 2,604 | $43,799 |
| 2026-11-16 | Friedl-Naderer Johanna | Chief Commercial Officer | 卖出 | 231 | $3,885 |
| 2026-10-22 | Kerr Douglas | Head of R&D and CMO | 买入 | 8,000 | $0 |
| 2026-10-06 | Posner Brian S | 董事 | 买入 | 2,500 | $40,000 |
| 2026-09-08 | Cox John | CEO & President | 卖出 | 5,658 | $106,823 |
| 2026-09-08 | Friedl-Naderer Johanna | Chief Commercial Officer | 卖出 | 900 | $21,915 |
| 2026-09-08 | Friedl-Naderer Johanna | Chief Commercial Officer | 卖出 | 185 | $3,493 |
| 2026-09-08 | Kerr Douglas | Chief Medical Officer | 卖出 | 3,745 | $91,191 |
| 2026-09-08 | Kerr Douglas | Chief Medical Officer | 卖出 | 1,290 | $24,355 |
| 2026-08-17 | Lucera Erick | Chief Financial Officer | 卖出 | 1,797 | $47,225 |
| 2026-08-17 | Friedl-Naderer Johanna | Chief Commercial Officer | 卖出 | 226 | $5,939 |
| 2026-08-17 | Rhodes Jason P | 董事 | 卖出 | 268,354 | $7.0M |
| 2026-08-17 | Rhodes Jason P | 董事 | 卖出 | 94,415 | $2.5M |
| 2026-08-17 | Rhodes Jason P | 董事 | 卖出 | 63,643 | $1.7M |
| 2026-08-17 | Rhodes Jason P | 董事 | 卖出 | 1.4M | $34.0M |
| 2026-08-17 | Rhodes Jason P | 董事 | 卖出 | 478,377 | $12.0M |
| 2026-08-17 | Rhodes Jason P | 董事 | 卖出 | 322,465 | $8.1M |
| 2026-08-17 | Kerr Douglas | Chief Medical Officer | 卖出 | 1,556 | $40,892 |
| 2026-08-17 | Cox John | CEO & President | 卖出 | 4,986 | $131,032 |
| 2026-07-29 | Kersten Dirk | 董事 | 卖出 | 256,072 | $6.5M |
| 2026-07-29 | Kersten Dirk | 董事 | 卖出 | 5,388 | $140,304 |
| 2026-07-08 | Rhodes Jason P | 董事 | 卖出 | 253,039 | $5.8M |
| 2026-07-08 | Rhodes Jason P | 董事 | 卖出 | 127,182 | $2.9M |
来源:SEC Form 4 申报文件 · 截至 2026-11-16